SOHM Inc. (OTC:SHMN) Stock In Focus After Announcing New Patent
This morning investors are expected to look into those stocks that may have come into sharp focus on Thursday. A stock that came into focus in a big way yesterday was the SOHM Inc. (OTC:SHMN) stock, and it is expected to be in focus among investors today.
Patent Allowance
Yesterday the company came into focus among investors after it announced that the Japanese Patent Office had awarded it the Official Notice of Patent Allowance. The patent is entitled “CAS 9 RETROVIRAL INTEGRASE AND CAS 9 RECOMBINASE SYSTEMS FOR TARGETED INCORPORATION OF A DNA SEQUENCE INTO A GENOME OF A CELL OR ORGANISM.” It would protect SOHM’s ABBIE genome editing solutions and products.
More About ABBIE
ABBIE Genome Editing is a bio-validated and innovative offering from SOHM. It offers game-changing, proprietary, and advanced methods in gene editing. In the news release, the company also announced that it also provided a genome editing offering known as SAGE.
The latest patent award was a significant new development for SOHM since it further boosted the international intellectual property portfolio of the company. Moreover, it would enable the entry into a highly lucrative market. It remains to be seen if the SOHM stock gets any traction today to end the week on a strong note.
Technicals
| +/- EMA(20) | 0.001 (-10.00%) |
| +/- SMA(50) | 0.0011 (-18.18%) |
| +/- SMA(200) | 0.0012 (-25.00%) |
| 5-Day Perf. | -10% |
| 1-Month Perf. | -25% |
| 3-Month Perf. | – |
| 6-Month Perf. | -18.18% |
| YTD Perf. | -35.71% |
| 1-Year Perf. | -35.71% |
| RSI(14) | 40.97 |
| ATR(14) | – |
| ADX(14) | 20.9 |
